Status:
COMPLETED
Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery
Lead Sponsor:
Iladevi Cataract and IOL Research Center
Conditions:
Inflammation
Eligibility:
All Genders
Up to 15 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if intraocular infusion of low-molecular weight heparin (enoxaparin) influences postoperative inflammation following pediatric cataract surgery with intraocul...
Detailed Description
Despite advances in cataract surgery in children, postoperative inflammation is a significant complication following pediatric cataract surgery. Any drug that prevents or decreases this inflammation w...
Eligibility Criteria
Inclusion
- Children (0-15 years) with congenital cataract scheduled for surgery with IOL implantation and informed consent from the parents/legal guardian
Exclusion
- Preoperative: Associated ocular anomalies (uveitis, microphthalmos, persistent fetal vasculature, aniridia, glaucoma, iris coloboma), traumatic cataract
- Intraoperative: Inability to implant IOL in the capsular bag, intraoperative complications- iris trauma, vitreous disturbance, descemet's detachment
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00986076
Start Date
March 1 2008
End Date
September 1 2009
Last Update
September 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iladevi Cataract & IOL Research Centre
Ahmedabad, Gujarat, India, 380052